April M Ketchum, LCMHC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 35 Ayers Brook Rd, Randolph, VT 05060 Phone: 802-728-4466 Fax: 802-728-4197 |
Linda Chambers, LADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 11 S Main St, Randolph, VT 05060 Phone: 802-728-4466 Fax: 802-728-4197 |
Kate E Lohutko, LCMHC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 35 Ayers Brook Rd, Randolph, VT 05060 Phone: 802-728-4466 |
Evelyn Zoecklein, LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 11 S Main St, Randolph, VT 05060 Phone: 802-728-4466 Fax: 802-728-4197 |
Elizabeth Macaulay, LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 11 S Main St, P.o. Box G, Randolph, VT 05060 Phone: 802-222-4477 Fax: 802-222-3242 |
Carol Pierce, LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 11 S Main St, Randolph, VT 05060 Phone: 802-728-4466 Fax: 802-728-4197 |
News Archive
A new initiative launched by the Institute for Clinical Systems Improvement, a nonprofit, health care improvement organization, could save the Minnesota health care community more than $28 million annually, as well as improve patient care and provider groups' productivity.
In a post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Kerry Gallo of Children Without Worms writes, "Effective control strategies for several NTDs such as soil-transmitted helminthiasis (STH), trachoma, and schistosomiasis require that communities have access to water and latrines to break the cycle of infection," concluding, "The intertwined nature of water and sanitation issues and NTD control shows that our two sectors should work together in partnership to improve the health of communities and maximize impact".
Research using registry data can contribute a great deal to the improvement of health and healthcare. Sweden is uniquely positioned in this respect, but the resources remain under-exploited, and there are methodological and financing problems that need resolving.
Sunovion Pharmaceuticals Canada Inc., formerly Sepracor Pharmaceuticals, Inc., today announced that the New Drug Submission (NDS) for Lurasidone HCl, for the treatment of adult patients with schizophrenia has been accepted for review by Health Canada. The NDS was submitted to Health Canada in June 2011 and will receive a standard review.
› Verified 7 days ago